Ugro Capital receives BSE, NSE observations for amalgamation scheme
Ugro Capital received observation letters from BSE and NSE regarding its amalgamation scheme with Profectus Capital Private Limited. The exchanges issued 'no adverse observation' and 'no objection' respectively, valid for six months. SEBI mandated disclosures regarding legal proceedings, financials, and liabilities transfer.

*this image is generated using AI for illustrative purposes only.
Ugro Capital Limited has received observation letters from BSE Limited and National Stock Exchange of India Limited regarding its scheme of amalgamation with Profectus Capital Private Limited. The exchanges issued their observations on July 10, 2026, and July 09, 2026, respectively, following a review of the draft scheme submitted by the company.
BSE, in its letter, stated it has no adverse observations with limited reference to matters having a bearing on listing requirements. Similarly, NSE conveyed its 'no objection' in terms of Regulation 37 and 59A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Both letters are valid for six months from their respective dates of issue, within which the company must submit the scheme to the National Company Law Tribunal (NCLT).
The observations were issued based on comments received from the Securities and Exchange Board of India (SEBI). SEBI, via letters dated May 22, 2026, and July 08, 2026, directed the entities to ensure full disclosure of ongoing adjudication, recovery proceedings, and enforcement actions against the company, its promoters, and directors before the NCLT and shareholders. The regulator also mandated that all liabilities of the transferor company be transferred to the transferee company.
Key SEBI Comments and Requirements
The exchanges incorporated several specific comments from SEBI that the company must address. These include requirements related to financial data, disclosures to shareholders, and compliance with various regulations.
| Requirement | Details |
|---|---|
| Financials | Financials in the scheme, including those for the valuation report, must not be older than six months. |
| Unlisted Entity | Information about the unlisted entity must be included in the format specified for an abridged prospectus. |
| Shareholder Notice | The notice to shareholders must prominently disclose details of the proposed scheme and include a certificate from Maheshwari & Co., Chartered Accountants, dated May 15, 2026, certifying pre and post-scheme reserve balances. |
| Liabilities | All liabilities of the Transferor Company must be transferred to the Transferee Company. |
| NCD Holders | Disclosures to holders of Non-Convertible Debentures (NCDs) must be certified by a SEBI-registered merchant banker. |
The company is required to disclose the No-Objection letters from the stock exchanges on its website within 24 hours of receipt. Additionally, any additional information submitted to the exchanges post-filing must be displayed on the company's and the exchanges' websites. The exchanges reserved the right to withdraw their observations if any information provided is found to be incomplete, incorrect, misleading, or false.
The scheme remains subject to necessary approvals, including those from shareholders, creditors, and the NCLT. Ugro Capital stated it would inform the exchanges of further developments regarding the scheme.
Historical Stock Returns for UGRO Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.25% | -2.37% | -2.59% | -40.22% | -46.72% | -14.75% |
How will the mandatory transfer of all liabilities to the transferee company impact Ugro Capital's balance sheet and debt ratios post-merger?
Will the requirement to disclose ongoing adjudication and enforcement actions against promoters influence shareholder voting behavior during the approval process?
Can Ugro Capital secure the necessary NCLT and creditor approvals within the six-month validity period set by the exchanges?































